- Home
- CASS vs SLRN Comparison
CASS vs SLRN Comparison
Compare CASS & SLRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CASS
- SLRN
- Stock Information
- Founded
- CASS 1906
- SLRN 2020
- Country
- CASS United States
- SLRN United States
- Employees
- CASS N/A
- SLRN N/A
- Industry
- CASS Business Services
- SLRN Biotechnology: Pharmaceutical Preparations
- Sector
- CASS Consumer Discretionary
- SLRN Health Care
- Exchange
- CASS Nasdaq
- SLRN Nasdaq
- Market Cap
- CASS 549.0M
- SLRN 485.6M
- IPO Year
- CASS 1996
- SLRN 2023
- Fundamental
- Price
- CASS $44.93
- SLRN $5.95
- Analyst Decision
- CASS Buy
- SLRN Buy
- Analyst Count
- CASS 1
- SLRN 6
- Target Price
- CASS $45.00
- SLRN $11.17
- AVG Volume (30 Days)
- CASS 46.3K
- SLRN 604.7K
- Earning Date
- CASS 10-17-2024
- SLRN 11-19-2024
- Dividend Yield
- CASS 2.72%
- SLRN N/A
- EPS Growth
- CASS N/A
- SLRN N/A
- EPS
- CASS 1.68
- SLRN N/A
- Revenue
- CASS $220,027,000.00
- SLRN N/A
- Revenue This Year
- CASS N/A
- SLRN N/A
- Revenue Next Year
- CASS $5.65
- SLRN N/A
- P/E Ratio
- CASS $27.48
- SLRN N/A
- Revenue Growth
- CASS 4.97
- SLRN N/A
- 52 Week Low
- CASS $37.99
- SLRN $3.36
- 52 Week High
- CASS $50.25
- SLRN $9.25
- Technical
- Relative Strength Index (RSI)
- CASS 62.42
- SLRN 54.77
- Support Level
- CASS $41.09
- SLRN $5.43
- Resistance Level
- CASS $47.14
- SLRN $6.48
- Average True Range (ATR)
- CASS 0.99
- SLRN 0.36
- MACD
- CASS 0.35
- SLRN -0.05
- Stochastic Oscillator
- CASS 70.22
- SLRN 51.38
About CASS Cass Information Systems Inc
Cass Information Systems Inc is a provider of payment and information processing services to large manufacturing, distribution and retail enterprises across the United States. The company provides transportation invoice rating, payment processing, auditing, accounting, and transportation information. It is also a processor and payer of energy invoices, including electricity, gas, waste, and other facility-related expenses. It operates in two segments: Information Services and Banking Services. The firm generates maximum revenue from the Information Services segment.
About SLRN ACELYRIN INC.
Acelyrin Inc is a late-stage clinical biopharmaceutical company. It is focused on providing patients life-changing new treatment options by identifying, acquiring, and accelerating development and commercialization of of transformative medicines.